-
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Cash
Wednesday, May 25, 2011 - 1:27am | 129Below are the top small-cap diagnostic substances stocks on the NYSE and NASDAQ in terms of cash. Immucor Inc (NASDAQ: BLUD) had $274.68 million in total cash and no debt for the latest quarter. AMAG Pharmaceuticals Inc (NASDAQ: AMAG) had $238.23 million in total cash and no debt for the latest...
-
William T. Boehm Joins Neogen's Board of Directors
Tuesday, May 17, 2011 - 8:46am | 46Neogen Corporation (Nasdaq: NEOG) announced today that William T. Boehm, a recently retired senior vice president of The Kroger Co. and former senior economist for the President's Council of Economic Advisors, was elected to Neogen's Board of Directors.
-
Mellanox Technologies Promotes Shai Cohen to Chief Operating Officer
Tuesday, May 17, 2011 - 8:33am | 96Mellanox® Technologies, Ltd. (NASDAQ: MLNX) today announced the promotion of Shai Cohen to chief operating officer (COO). Mr. Cohen will be reporting to Eyal Waldman, chairman, president and CEO. Shai Cohen is a co-founder of Mellanox and served as Mellanox's vice president of operations and...
-
UPDATE: Piper Jaffray Raises PT on TranS1 to $6 (TSON)
Friday, May 13, 2011 - 8:45am | 104Piper Jaffray is out with its report today on TranS1 (NASDAQ: TSON), raising its PT from $4.00 to $6.00. In a note to clients, Piper Jaffray writes, "We reiterate our Overweight rating and are increasing our PT to $6, based on 4.0x (prev. 2.5x) EV/2012E sales of $21.8 million. We are raising our...
-
Piper Jaffray Raises PT On TranS1 To $6
Friday, May 13, 2011 - 8:18am | 26Piper Jaffray has raised the price target on TranS1 (NASDAQ: TSON) from $4 to $6 and maintains its Overweight rating.
-
11 Stocks That Only Go Up
Thursday, May 12, 2011 - 8:45pm | 284This is by far, one of my favorite stock screens that I run. I have probably found more winning stocks (and big % ones at that) off of this screen, than any other one that I run. These stocks make it a habit to trade on their own merits and not that of the market itself. They are often...
-
Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze
Wednesday, May 11, 2011 - 7:29am | 148Halozyme Therapeutics, Inc. (Nasdaq: HALO) and ViroPharma Incorporated (Nasdaq: VPHM), today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 in the development of a subcutaneous formulation of Cinryze. Under terms of the agreement, Halozyme may receive...
-
RTI Biologics Splits Chairman and CEO Roles
Tuesday, May 10, 2011 - 4:30pm | 109RTI Biologics Inc. (Nasdaq: RTIX) announced today that the board of directors has separated the roles of chairman of the board and chief executive officer. Dean H. Bergy assumed the role of chairman of the board of directors effective May 5, 2011, while Brian K. Hutchison remains CEO of the...
-
Top Percentage Gainers and Losers as of 12pm 5/09/11 (SCEI, FFHL ROSE, SMI, DTG, HTZ, SYY, CERS, LFT, ZRAN, OXGN, MOBI, GKK, EBS, TSN)
Monday, May 9, 2011 - 12:06pm | 504Best 1) Sino Clean Energy (NASDAQ: SCEI): Trading up 26.2% from Friday's close to $2.64. Sino Clean announced a $20 million share repurchase program to take place over the next twelve months. 2) Fuwei Films (NASDAQ: FFHL): Trading up 23% from Friday's close to $3.42. Shares of Fuwei have broken...
-
Allergan Chief Executive David Pyott Says U.S. Botox Market is Growing About Mid Teens -CNBC (ALGN)
Monday, May 9, 2011 - 7:36am | 28On CNBC, Allergan's (NASDAQ: ALGN) Chief Executive David Pyott says the U.S. botox market is growing about mid teens.
-
CEOWORLD Most Actives Top Healthcare stocks picks on 5/4/11- GENE, SPPI, AMRI, GTXI, AFFX,KV.A, SCLN, CBM, CERS, CEPH, TEVA, THC, JNJ
Wednesday, May 4, 2011 - 6:59am | 1424Gainers (% price change): Genetic Tech. Ltd. (ADR) (GENE) engaged in a diagnostic product business is trading at a price of $8.18, a dramatic change of +2.41 (41.77%) from its previous day's close. Currently, the company has a Market capitalization (total value of a company in the stock market)...
-
Morgan Keegan Raises PT On HAE To $76
Tuesday, May 3, 2011 - 8:02am | 132Morgan Keegan, citing 4Q results, is raising its price target on Haemonetics Corp. (NYSE: HAE) from $73 to $76 and maintains a n Outperform rating on the stock. Says Morgan Keegan, in its report, “Haemonetics reported fiscal 4Q results that missed top-line expectations, but were 2% better than the...
-
Jefferies Comments On Dentsply Revised Forecasts
Tuesday, May 3, 2011 - 7:50am | 78According to Jefferies, Dentsply (NASDAQ: XRAY) price target is moved to $44. Jefferies said that its price target moves to $44 (from $42) on greater confidence in XRAY's ability to mitigate the near-term financial impact of disruption to its Japanese supplier. “Our $44 PT represents a 10-year...
-
Jefferies Raises PT On DENTSPLY To $44
Tuesday, May 3, 2011 - 5:48am | 26Jefferies & Company has raised the price target on DENTSPLY (NASDAQ: XRAY) from $42 to $44 and maintains its Buy rating.
-
CEOWORLD Top Medical Equipment and Supplies stocks- ELOS, FLDM, SURG, WWIN, KH, OSUR, AIS, TRNX, DCTH, ICUI
Monday, May 2, 2011 - 2:38pm | 1531ICU Medical, Incorporated (NASDAQ:ICUI)- ICU Medical, Inc. is engaged in the development, manufacture and sale of disposable medical connection systems for use in vascular therapy applications. The Company' devices are designed to protect patients from catheter-related bloodstream infections and...